Clinical Trials List
2009-03-01 - 2017-03-01
Phase III
Terminated6
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Liang-Tsai Hsiao Division of Hematology & Oncology
- 余垣斌 Division of Hematology & Oncology
- Jin-Hwang Liu Division of Hematology & Oncology
- 洪英中 Division of Hematology & Oncology
- Jyh-Pyng Gau Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shang-Ju Wu Division of Hematology & Oncology
- Jih-Luh Tang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wu-Chou Su Division of Hematology & Oncology
- Ya-Ping Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Su-Peng Yeh Division of Hematology & Oncology
- Li-Yuan Bai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
352 participants
